Buy These 3 Healthcare Mutual Funds to Strengthen Your Portfolio

One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services does not change with market conditions. Among the sector players, many pharmaceutical companies also pay out regular dividends.Companies that consistently offer dividends are financially stable and generate a steady cash flow, irrespective of market conditions. Mutual funds are the perfect choice for investors looking to enter this sector since they possess the advantages of broad diversification and analytical insight.Below, we share with you three healthcare mutual funds, namely Franklin Biotechnology Discovery Fund FBDIX, Janus Henderson Global Life Sciences Fund JNGLX and Fidelity Advisor Health Care FACTX. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of funds.Franklin Biotechnology Discovery Fund invests most of its net assets in equity securitiesof biotechnology companies and discovery research firms. FBDIX advisors may also invest a small portion of its net assets in net assets in equity or debt securities of any type of issuer.Franklin Biotechnology Discovery Fund has three-year annualized returns of 7.8%. As of the end of January 2025, FBDIX held 81 issues, with 6.7% of its assets invested in Amgen.Janus Henderson Global Life Sciences Fund invests most of its assets, along with borrowings, if any, in securities of companies that, according to its portfolio managers, have a life science orientation. JNGLX has a fundamental policy to invest at least a small portion of its assets in companies that belong to the "life sciences" sector.Janus Henderson Global Life Sciences Fund has five-year annualized returns of 7.3%. JNGLX has an expense ratio of 0.80%.Fidelity Advisor Health Care fund invests the majority of its net assets in common stocks of foreign and domestic companies that are engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. FACTX advisors choose to invest in stocks based on fundamental analysis factors such as the issuer's financial condition, industry position, as well as market and economic conditions.Fidelity Advisor Health Care fund has five-year annualized returns of 3.4%. Edward Yoonhas been the fund manager of FACTX since October 2008.To view the Zacks Rank and the past performance of all Healthcare mutual funds, investors can click here to see the complete list of healthcare mutual funds.Want key mutual fund info delivered straight to your inbox?Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>View All Zacks #1 Ranked Mutual FundsWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Get Your Free (FBDIX): Fund Analysis Report Get Your Free (JNGLX): Fund Analysis Report Get Your Free (FACTX): Fund Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks